Table 3.
Response to treatments of group 2 about gender and age group
| Age group | Male | Female |
|---|---|---|
| 20-30 years | 21 (35%) | 19(31%) |
| 30-40 | 8 (13.3%) | 6(10%) |
| 40-60 | 3 (5%) | 3(5%) |
| Cure cases | 19 (59.37%) | 20(71.4%) |
| Failure cases | 13 (40.6%) | 8(28.57%) |
Response to treatments of group 2 about gender and age group
| Age group | Male | Female |
|---|---|---|
| 20-30 years | 21 (35%) | 19(31%) |
| 30-40 | 8 (13.3%) | 6(10%) |
| 40-60 | 3 (5%) | 3(5%) |
| Cure cases | 19 (59.37%) | 20(71.4%) |
| Failure cases | 13 (40.6%) | 8(28.57%) |